# Clinical trials recruiting in New Zealand: 359 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 359 trials recruiting or not yet recruiting with a site in New Zealand, as read on November 19, 2026.

## The full list

Clinical trials recruiting in New Zealand: 359 rows for $17.95, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/new-zealand

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 359
- Recruiting or not yet: 359
- Read on: November 19, 2026

## Trials

The 25 newest of 359, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944326 | Cardiovascular and Renal Protection With SGLT Inhibition in Kidney Transplant Recipients: The RENAISSANCE Trial | University of British Columbia | Phase 3 | Not yet recruiting | Kidney Transplant Recipient | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944326) |
| November 9, 2026 | NCT07924397 | A Study to Assess IG001643 in Healthy Participants | Iongen Therapeutics Co., Ltd. | Phase 1 | Not yet recruiting | Pain Management | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924397) |
| November 4, 2026 | NCT07916961 | Study of AB-110 in Healthy and Hypertensive Participants | Antlia Bioscience, Inc | Phase 1 | Not yet recruiting | Hypertension (HTN), Healthy Adult Participants | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916961) |
| October 23, 2026 | NCT07891949 | Plasmonic PhotoThermal Therapy (PPTT) With Glucose-Coated Gold Nanoparticles (TSK-001) in Patients With Nodular Basal Cell Carcinoma (nBCC) | Torskal SAS | Not applicable | Not yet recruiting | Nodular BCC | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891949) |
| October 5, 2026 | NCT07858019 | A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers | Corsera Health | Phase 1 | Not yet recruiting | Otherwise Healthy Individuals With Systolic Blood Pressure (SBP) From 110 to 139 mmHg and Low-density Lipoprotein... | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858019) |
| October 2, 2026 | NCT07856095 | A Study of a Device That Helps Place Dialysis Needles | X9, Inc. | Not applicable | Not yet recruiting | Dialysis, Cannulation, Vascular Access | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856095) |
| October 1, 2026 | NCT07850999 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Participants With Mild Hepatic Impairment Compared With... | Assembly Biosciences | Phase 1 | Not yet recruiting | Mild Hepatic Imparement | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850999) |
| September 23, 2026 | NCT07836530 | Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular Carcinoma | BeOne Medicines | Phase 3 | Recruiting | Hepatocellular Carcinoma, Liver Cancer | 492 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836530) |
| September 21, 2026 | NCT07831798 | VV-14300 for the Treatment of Type 1 Diabetes | Kriya Therapeutics, Inc. | Phase 1/2 | Recruiting | Type 1 Diabetes Mellitus | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831798) |
| September 21, 2026 | NCT07830108 | ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With... | Starship Child Health, Te Toka Tumai Auckland | Phase 3 | Not yet recruiting | Rheumatic Fever, Rheumatic Heart Disease in Children, Acute Rheumatic Fever, Rheumatic Heart Disease | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830108) |
| September 15, 2026 | NCT07820631 | First-in-Human Study of the Circle Safe System for Diaphragm Response Monitoring During Pulmonary Vein Ablation | Circle Safe, Inc. | Not applicable | Not yet recruiting | Atrial Fibrillation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820631) |
| September 9, 2026 | NCT07811063 | A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729 | Tortugas Neuroscience, Inc. | Phase 1 | Recruiting | Healthy Volunteers | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811063) |
| September 9, 2026 | NCT07810777 | PRA-216 Atopic Dermatitis Safety and Efficacy Study | Prana Therapies Inc | Phase 2 | Recruiting | Atopic Dermatitis (AD) | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810777) |
| September 1, 2026 | NCT07798609 | A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD | Soufflé Therapeutics, Inc. | Phase 1/2 | Recruiting | Facioscapulohumeral Muscular Dystrophy (FSHD) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798609) |
| August 28, 2026 | NCT07792928 | A Study of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults | Shanghai Peptidstar Therapeutics Limited | Phase 1 | Not yet recruiting | Psoriasis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792928) |
| August 20, 2026 | NCT07777549 | A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B) | Tortugas Neuroscience, Inc. | Phase 2 | Recruiting | Tinnitus | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777549) |
| August 20, 2026 | NCT07775339 | Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia | LIB Therapeutics LLC | Phase 3 | Not yet recruiting | Heterozygous Familial Hypercholesterolemia (HeFH) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775339) |
| August 18, 2026 | NCT07769970 | Restoring Independence With Stimulation-Enhanced Treatment for People With Functional Neurological Disorder | University of Auckland, New Zealand | Not applicable | Not yet recruiting | Functional Neurological Disorder, Conversion Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769970) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| August 10, 2026 | NCT07754461 | A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Boehringer Ingelheim | Phase 3 | Recruiting | Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754461) |
| August 5, 2026 | NCT07748403 | A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) | Prime Medicine, Inc. | Phase 1/2 | Recruiting | Wilson Disease, Wilson's Disease, Wilsons Disease | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748403) |
| August 4, 2026 | NCT07746141 | A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic... | BeOne Medicines | Phase 1 | Recruiting | RAS Mutation, Advanced Solid Tumor, Metastatic Solid Tumor | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746141) |
| August 4, 2026 | NCT07744828 | A Study to Evaluate Pharmacokinetics of DRL\_AB in Healthy Male Participants | Dr. Reddy's Laboratories Limited, India | Phase 1 | Not yet recruiting | Healthy Volunteers | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07744828) |
| August 3, 2026 | NCT07741656 | A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP) | Andromeda Surgical | Not applicable | Recruiting | BPH (Benign Prostatic Hyperplasia), HoLEP (Holmium Laser Enucleation of Prostate) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741656) |
| July 31, 2026 | NCT07739342 | Evaluating the Occurrence of DKA in People With Type I Diabetes | Abbott Diabetes Care | Observational | Not yet recruiting | Type 1 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739342) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Auckland City Hospital | Auckland | 83 |
| Christchurch Hospital | Christchurch | 40 |
| Waikato Hospital | Hamilton | 39 |
| Starship Children's Hospital | Grafton | 28 |
| North Shore Hospital | Takpuna Auckland | 19 |
| Aotearoa Clinical Trials | Auckland | 17 |
| New Zealand Clinical Research | Grafton | 16 |
| Dunedin Hospital | Dunedin | 16 |
| Wellington Hospital | Wellington | 15 |
| Middlemore Hospital | Auckland | 14 |
| Wellington Regional Hospital | Wellington | 9 |
| Tauranga Hospital | Tauranga | 7 |
| New Zealand Clinical Research (NZCR) | Grafton | 7 |
| Palmerston North Hospital | Palmerston North | 6 |
| University of Auckland | Auckland | 6 |
| Rotorua Hospital | Rotorua | 5 |
| Auckland Hospital | Grafton | 5 |
| Taranaki Base Hospital | New Plymouth | 4 |
| Momentum Clinical Research | Waikanae Beach | 4 |
| Momentum Clinical Research Dunedin | Dunedin | 4 |
| New Zealand Clinical Research - Christchurch | Christchurch | 4 |
| Wellington Regional Hospital (Ccdhb) | Wellington | 4 |
| Christchurch Heart Institute | Christchurch | 3 |
| Hutt Hospital | Lower Hutt | 3 |
| ChristChurch Hospital | Christchurch | 3 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1 | 50 |
| Phase 1/2 | 33 |
| Phase 2 | 45 |
| Phase 2/3 | 14 |
| Phase 3 | 105 |
| Phase 4 | 8 |
| Not applicable | 64 |
| Observational | 37 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Breast Neoplasms | 9 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Neoplasms | 7 |
| Heart Failure | 7 |
| Hepatitis B, Chronic | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Diffuse Intrinsic Pontine Glioma | 6 |
| Atrial Fibrillation | 6 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 5 |
| Hypertension | 5 |
| Cardiovascular Diseases | 5 |
| Prostatic Neoplasms | 5 |
| Carcinoma, Hepatocellular | 5 |
| Recurrence | 5 |
| Glioma | 5 |
| Kidney Diseases | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Aortic Aneurysm, Abdominal | 4 |
| Aortic Valve Stenosis | 4 |
| Dermatitis, Atopic | 4 |
| Lymphoma, B-Cell | 4 |
| Neoplasm Metastasis | 4 |
| Astrocytoma | 4 |
| Glioblastoma | 4 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 20 |
| [BeOne Medicines](https://specstream.ai/data/clinical-trials/company/beone-medicines) | 14 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 10 |
| University of Auckland, New Zealand | 9 |
| Children's Oncology Group | 8 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 8 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 5 |
| Monash University | 5 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 5 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 4 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 4 |
| Kriya Therapeutics, Inc. | 4 |
| Nationwide Children's Hospital | 4 |
| [Arrowhead Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/arrowhead-pharmaceuticals) | 4 |
| Australian and New Zealand Intensive Care Research Centre | 4 |
| [Fisher and Paykel Healthcare](https://specstream.ai/data/clinical-trials/company/fisher-and-paykel-healthcare) | 4 |
| University of Sydney | 4 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 3 |
| The George Institute | 3 |
| University of Birmingham | 3 |
| Murdoch Childrens Research Institute | 3 |
| The University of Queensland | 3 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 3 |
| AusperBio Therapeutics Inc. | 2 |
| University College, London | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Auto insurance agencies in the United States](https://specstream.ai/data/businesses/auto-insurance-agencies/united-states)
- [Industrial cleaning companies in the United States](https://specstream.ai/data/businesses/industrial-cleaning-companies/united-states)
- [Valet services in the United States](https://specstream.ai/data/businesses/valet-services/united-states)
- [Flight schools in the United States](https://specstream.ai/data/businesses/flight-schools/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Dentistry schools in the United States](https://specstream.ai/data/businesses/dentistry-schools/united-states)
